We are developing gene therapy and stem cell treatments for retinal diseases
Our clinical and laboratory research is dedicated to finding new treatments for blindness, particularly in patients with incurable retinal diseases. In addition to developing gene therapy with new adeno-associated viral (AAV) vectors in the laboratory, we are currently leading a gene therapy trial to treat choroideremia.
We are also developing treatments for other macular and retinal degenerations. We have a clinical research programme in artifical vision with bio-genetic and electronic devices in collaboration with Retina Implant AG. In the clinic we are testing new imaging methods for retinal diseases and in the operating theatre we are developing new eye surgery techniques for age-related macular degeneration, cataract and macular hole surgery.